Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | Clan U, family U48, CaaX prenyl peptidase 2-like | 0.0099 | 0.4935 | 0.5 |
Mycobacterium ulcerans | hypothetical protein | 0.002 | 0.0202 | 0.5 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0054 | 0.2216 | 0.449 |
Echinococcus granulosus | bromodomain adjacent to zinc finger domain | 0.0065 | 0.2857 | 0.2857 |
Loa Loa (eye worm) | PHD-finger family protein | 0.0022 | 0.0315 | 0.0637 |
Brugia malayi | Bromodomain containing protein | 0.0081 | 0.3853 | 0.7807 |
Schistosoma mansoni | family U48 unassigned peptidase (U48 family) | 0.0099 | 0.4935 | 0.4935 |
Echinococcus granulosus | bromodomain adjacent to zinc finger domain | 0.0039 | 0.131 | 0.131 |
Echinococcus multilocularis | zinc finger protein | 0.0021 | 0.0246 | 0.0246 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0037 | 0.119 | 0.241 |
Schistosoma mansoni | family U48 unassigned peptidase (U48 family) | 0.0099 | 0.4935 | 0.4935 |
Trypanosoma cruzi | peptidase with unknown catalytic mechanism (family U48) | 0.0099 | 0.4935 | 1 |
Leishmania major | CAAX prenyl protease 2, putative,peptidase with unknown catalytic mechanism (family U48) | 0.0099 | 0.4935 | 1 |
Plasmodium falciparum | protease, putative | 0.002 | 0.0202 | 1 |
Schistosoma mansoni | methyl-cpg binding protein mbd | 0.0018 | 0.0082 | 0.0082 |
Mycobacterium ulcerans | hypothetical protein | 0.002 | 0.0202 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0077 | 0.3574 | 0.7243 |
Chlamydia trachomatis | hypothetical protein | 0.002 | 0.0202 | 0.5 |
Echinococcus granulosus | fetal alzheimer antigen falz | 0.0024 | 0.0439 | 0.0439 |
Echinococcus granulosus | histone lysine methyltransferase setb | 0.0018 | 0.0082 | 0.0082 |
Echinococcus granulosus | methyl CpG binding domain protein 2 | 0.0018 | 0.0082 | 0.0082 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.002 | 0.0202 | 1 |
Echinococcus multilocularis | bromodomain adjacent to zinc finger domain | 0.0039 | 0.131 | 0.131 |
Echinococcus multilocularis | bromodomain adjacent to zinc finger domain | 0.0065 | 0.2857 | 0.2857 |
Mycobacterium tuberculosis | Probable integral membrane protein | 0.002 | 0.0202 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0042 | 0.1469 | 0.2976 |
Mycobacterium tuberculosis | Probable conserved integral membrane protein | 0.002 | 0.0202 | 1 |
Schistosoma mansoni | acetyl-CoA C-acetyltransferase | 0.0024 | 0.0439 | 0.0439 |
Toxoplasma gondii | CAAX amino terminal protease family protein | 0.002 | 0.0202 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0184 | 1 | 1 |
Toxoplasma gondii | hypothetical protein | 0.002 | 0.0202 | 1 |
Plasmodium vivax | protease, putative | 0.002 | 0.0202 | 1 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0054 | 0.2216 | 0.449 |
Loa Loa (eye worm) | hypothetical protein | 0.0018 | 0.0082 | 0.0165 |
Loa Loa (eye worm) | hypothetical protein | 0.0046 | 0.1747 | 0.354 |
Schistosoma mansoni | methyl-cpg binding protein mbd | 0.0018 | 0.0082 | 0.0082 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0054 | 0.2216 | 0.449 |
Entamoeba histolytica | CAAX prenyl protease family | 0.0099 | 0.4935 | 1 |
Echinococcus multilocularis | CAAX prenyl protease 2 | 0.0099 | 0.4935 | 0.4935 |
Echinococcus multilocularis | methyl CpG binding domain protein 2 | 0.0018 | 0.0082 | 0.0082 |
Brugia malayi | CAAX amino terminal protease family protein | 0.0099 | 0.4935 | 1 |
Schistosoma mansoni | bromodomain containing protein | 0.0069 | 0.309 | 0.309 |
Brugia malayi | Bromodomain containing protein | 0.0042 | 0.1464 | 0.2967 |
Schistosoma mansoni | zinc finger protein | 0.0021 | 0.0246 | 0.0246 |
Brugia malayi | PHD-finger family protein | 0.0027 | 0.0593 | 0.1202 |
Schistosoma mansoni | hypothetical protein | 0.0022 | 0.0315 | 0.0315 |
Loa Loa (eye worm) | hypothetical protein | 0.0054 | 0.2216 | 0.449 |
Loa Loa (eye worm) | hypothetical protein | 0.0044 | 0.1623 | 0.3289 |
Echinococcus granulosus | CAAX prenyl protease 2 | 0.0099 | 0.4935 | 0.4935 |
Trypanosoma cruzi | CAAX prenyl protease 2, putative | 0.0099 | 0.4935 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0099 | 0.4935 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0037 | 0.119 | 0.119 |
Schistosoma mansoni | hypothetical protein | 0.0184 | 1 | 1 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0018 | 0.0082 | 0.0082 |
Treponema pallidum | hypothetical protein | 0.002 | 0.0202 | 0.5 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0018 | 0.0082 | 0.0082 |
Echinococcus multilocularis | histone lysine methyltransferase setb histone lysine methyltransferase eggless | 0.0018 | 0.0082 | 0.0082 |
Giardia lamblia | Hypothetical protein | 0.0099 | 0.4935 | 0.5 |
Echinococcus multilocularis | geminin | 0.0184 | 1 | 1 |
Trypanosoma brucei | CAAX amino terminal protease, putative | 0.0099 | 0.4935 | 1 |
Mycobacterium ulcerans | integral membrane protein | 0.002 | 0.0202 | 0.5 |
Echinococcus multilocularis | fetal alzheimer antigen, falz | 0.0024 | 0.0439 | 0.0439 |
Loa Loa (eye worm) | bromodomain containing protein | 0.0019 | 0.0122 | 0.0246 |
Toxoplasma gondii | hypothetical protein | 0.002 | 0.0202 | 1 |
Mycobacterium tuberculosis | Probable conserved integral membrane protein | 0.002 | 0.0202 | 1 |
Echinococcus granulosus | zinc finger protein | 0.0021 | 0.0246 | 0.0246 |
Loa Loa (eye worm) | hypothetical protein | 0.0037 | 0.119 | 0.241 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
MIC (functional) | = 32 ug ml-1 | Antibacterial activity against Escherichia coli NCIM 2065 after 24 hrs by NCCLS agar well diffusion method | ChEMBL. | 22981328 |
MIC (functional) | = 64 ug ml-1 | Antifungal activity against Candida albicans NCIM 3102 after 48 hrs by NCCLS agar well diffusion method | ChEMBL. | 22981328 |
MTD (ADMET) | = 2000 mg kg-1 | Toxicity in mouse assessed as changes in vital functions | ChEMBL. | 22981328 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.